Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Rush

Showing results (351-360 of 565) with videos related to

Pageof 57
Sort By:
Journal of Affective Disorders|March 24, 2025
Characterizing the effects of vagus nerve stimulation on symptom improvement in markedly treatment-resistant major depressive disorder: A RECOVER trial reportHarold A Sackeim, Charles R Conway, Scott T Aaronson, et al.
Journal of Affective Disorders|February 17, 2009
Clinical correlates of the worsening or emergence of suicidal ideation during SSRI treatment of depression: an examination of citalopram in the STAR*D studySidney Zisook, Madhukar H Trivedi, Diane Warden, et al.
Journal of Affective Disorders|April 13, 2018
Psychometric properties of the concise health risk tracking (CHRT) in adolescents with suicidalityTaryn L Mayes, Betsy D Kennard, Michael Killian, et al.
Comprehensive Psychiatry|April 9, 2008
Sex differences in depression symptoms in treatment-seeking adults: confirmatory analyses from the Sequenced Treatment Alternatives to Relieve Depression studySheila M Marcus, Kevin B Kerber, A John Rush, et al.
Menopause (New York, N.Y.)|July 10, 2010
The influence of menopause status and postmenopausal use of hormone therapy on presentation of major depression in womenSusan G Kornstein, Elizabeth A Young, Annie T Harvey, et al.
Journal of Affective Disorders|May 16, 2025
A digital therapeutic (CT-152) as adjunct to antidepressant medication: A phase 3 randomized controlled trial (the Mirai study)Brian Rothman, Mary Slomkowski, Austin Speier, et al.
Psychiatric Services (Washington, D.C.)|June 7, 2006
Comparison of self-report and clinician ratings on two inventories of depressive symptomatologyA John Rush, Thomas J Carmody, Hisham M Ibrahim, et al.
CNS Spectrums|November 6, 2009
Factors associated with concomitant psychotropic drug use in the treatment of major depression: a STAR*D ReportRchard C Shelton, Steve D Hollon, Stephen R Wisniewski, et al.
Psychiatric Services (Washington, D.C.)|October 31, 2008
Depression outcomes of Spanish- and english-speaking Hispanic outpatients in STAR*DIra Lesser, Aurora Rosales, Sidney Zisook, et al.
Psychiatric Services (Washington, D.C.)|October 5, 2011
Effects of race and ethnicity on depression treatment outcomes: the CO-MED trialIra M Lesser, Sidney Zisook, Bradley N Gaynes, et al.
Pageof 57

Showing results (351-360 of 565) with videos related to

Sort By:
Pageof 57
Journal of Affective Disorders|March 24, 2025
Characterizing the effects of vagus nerve stimulation on symptom improvement in markedly treatment-resistant major depressive disorder: A RECOVER trial reportHarold A Sackeim, Charles R Conway, Scott T Aaronson, et al.
Journal of Affective Disorders|February 17, 2009
Clinical correlates of the worsening or emergence of suicidal ideation during SSRI treatment of depression: an examination of citalopram in the STAR*D studySidney Zisook, Madhukar H Trivedi, Diane Warden, et al.
Journal of Affective Disorders|April 13, 2018
Psychometric properties of the concise health risk tracking (CHRT) in adolescents with suicidalityTaryn L Mayes, Betsy D Kennard, Michael Killian, et al.
Comprehensive Psychiatry|April 9, 2008
Sex differences in depression symptoms in treatment-seeking adults: confirmatory analyses from the Sequenced Treatment Alternatives to Relieve Depression studySheila M Marcus, Kevin B Kerber, A John Rush, et al.
Menopause (New York, N.Y.)|July 10, 2010
The influence of menopause status and postmenopausal use of hormone therapy on presentation of major depression in womenSusan G Kornstein, Elizabeth A Young, Annie T Harvey, et al.
Journal of Affective Disorders|May 16, 2025
A digital therapeutic (CT-152) as adjunct to antidepressant medication: A phase 3 randomized controlled trial (the Mirai study)Brian Rothman, Mary Slomkowski, Austin Speier, et al.
Psychiatric Services (Washington, D.C.)|June 7, 2006
Comparison of self-report and clinician ratings on two inventories of depressive symptomatologyA John Rush, Thomas J Carmody, Hisham M Ibrahim, et al.
CNS Spectrums|November 6, 2009
Factors associated with concomitant psychotropic drug use in the treatment of major depression: a STAR*D ReportRchard C Shelton, Steve D Hollon, Stephen R Wisniewski, et al.
Psychiatric Services (Washington, D.C.)|October 31, 2008
Depression outcomes of Spanish- and english-speaking Hispanic outpatients in STAR*DIra Lesser, Aurora Rosales, Sidney Zisook, et al.
Psychiatric Services (Washington, D.C.)|October 5, 2011
Effects of race and ethnicity on depression treatment outcomes: the CO-MED trialIra M Lesser, Sidney Zisook, Bradley N Gaynes, et al.
Pageof 57